Topical salmeterol reduces protein content of nasal lavage fluid in response to allergen and histamine challenge: Double-blind cross-over placebo-controlled studies in adults

American Journal of Rhinology

Volumn 10, Issue 4, 1996, Pages 251-256

  Birchall, Martin A ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALLERGEN; HISTAMINE; LYSOZYME; MUCIN; PLACEBO; PROTEIN; SALBUTAMOL; SALMETEROL; TRYPTASE;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; INTRANASAL DRUG ADMINISTRATION; LAVAGE; NOSE;

EID: 0029794247     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065896782103108     Document Type: Article

References (7)

1. Baker AJ, Fuller RW. Anti-inflammatory effect of salmeterol on human alveolar macrophages. Am Rev Respir Dis 141:A394, 1990.
2. Butchers PR, Cousins SA, Vardey CJ. Salmeterol: A potent and long-acting inhibitor of the release of inflammatory and spasmogenic mediators from human lung. Br J Pharmacol 92:745, 1987.
3. Borum P, Mygind N, Larsen FS. The antiallergic effect of the beta2-adrenergic agent fenoterol in the nose. Eur J Respir Dis 64:44-48, 1983.
4. Stewart EJ, Cinnamond MJ, Nicholls P, Stanford CF. The influence of beta-adrenoceptors on nasal mucosal function. Rhinology 31:121-124, 1993.
5. Raphael GD, Meredith SD, Baraniuk JN, et al. The pathophysiology of rhinitis II. Assessment of sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis 139:791-800, 1989.
6. Raphael GD, Jeney EV, Baraniuk JN, et al. Pathophysiology of rhinitis: Lactoferrin and lysozyme in nasal secretions. J Clin Invest 84:1528-1535, 1989.
7. Pipkom U. Budesonide and nasal allergen challenge testing in man. Allergy 37:129-134, 1982.